Skip to content

A cohort study about fine treatment of interstitial pneumonia with autoimmune features

A cohort study about fine treatment of interstitial pneumonia with autoimmune features

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073952
Enrollment
Unknown
Registered
2023-07-26
Start date
2023-07-26
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial pneumonia with autoimmune features

Interventions

using anti-fibrotic drugs Group:NA
without using anti-fibrotic drugs Group:NA

Sponsors

Peking Union Medical Collage Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: age = 18 years old 2: clinical diagnosed as IPAF according to 2015 diagnostic criteria 3: the ANCA was positive without any systematic involvement 4: patient's consent was acquired.

Exclusion criteria

Exclusion criteria: 1: With known factors attributed to ILD, such as allergy and drugs 2: Patients together with disease such as malignant tumor whose lifespan expectancy is shorter than 1 year 3: Patient's consent was not able to acquire.

Design outcomes

Primary

MeasureTime frame
the degree of decline in FVC;

Secondary

MeasureTime frame
mortality;the incidence of CTD transformation; the degree of decline in FVC;single/multiple factors analysis for patients' prognosis;the change of chest HRCT;the incidence/time of acute exacerbation;

Countries

China

Contacts

Public ContactShao Chi

Peking Union Medical Collage Hospital

shaochi@live.com+86 138 1021 9574

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026